PLoS ONE (Jan 2022)

Epidemiology and risk factors related to severity of clinical manifestations of COVID-19 in outpatients: A retrospective study in Haiti

  • Mentor Ali Ber Lucien,
  • Katilla Pierre,
  • Gladzdin Jean-Denis,
  • Jonas Rigodon,
  • Caitlin M. Worrell,
  • Alexia Couture,
  • Aspen Flynn,
  • Mauricio Cerpa Calderon,
  • Luis Felipe Codina,
  • Andrea S. Vicari,
  • Samson Marseille,
  • Koama T. Jean Baptiste,
  • Bernadette Fouche,
  • Gerard Joseph,
  • Ito Journel,
  • Kenold Rendel,
  • Yoran Grant-Greene,
  • Nadia P. Jean-Charles,
  • Donald Lafontant,
  • Senou Amouzou,
  • Wilnique Pierre,
  • Marie Greta Roy Clement,
  • Stanley Juin,
  • Jacques Boncy,
  • Patrick Dely

Journal volume & issue
Vol. 17, no. 9

Abstract

Read online

Background Haiti’s first COVID-19 cases were confirmed on March 18, 2020, and subsequently spread throughout the country. The objective of this study was to describe clinical manifestations of COVID-19 in Haitian outpatients and to identify risk factors for severity of clinical manifestations. Methods We conducted a retrospective study of COVID-19 outpatients diagnosed from March 18-August 4, 2020, using demographic, epidemiological, and clinical data reported to the Ministry of Health (MoH). We used univariate and multivariate analysis, including multivariable logistic regression, to explore the risk factors and specific symptoms related to persons with symptomatic COVID-19 and the severity of symptomatic COVID-19 disease. Results Of 5,389 cases reported to MOH during the study period, 1,754 (32.5%) were asymptomatic. Amongst symptomatic persons 2,747 (75.6%) had mild COVID-19 and 888 (24.4%) had moderate-to-severe disease; the most common symptoms were fever (69.6%), cough (51.9%), and myalgia (45.8%). The odds of having moderate-to-severe disease were highest among persons with hypertension (aOR = 1.72, 95% Confidence Interval [CI] (1.34, 2.20), chronic pulmonary disease (aOR = 3.93, 95% CI (1.93, 8.17)) and tuberculosis (aOR = 3.44, 95% CI (1.35, 9.14)) compared to persons without those conditions. The odds of having moderate-to-severe disease increased with age but was also seen among children aged 0–4 years (OR: 1.73, 95% CI (0.93, 3.08)), when using 30–39 years old as the reference group. All of the older age groups, 50–64 years, 65–74 years, 75–84 years, and 85+ years, had significantly higher odds of having moderate-to-severe COVID-19 compared with ages 30–39 years. Diabetes was associated with elevated odds of moderate-to-severe disease in bivariate analysis (OR = 2.17, 95% CI (1.58,2.98) but, this association did not hold in multivariable analyses (aOR = 1.22,95%CI (0.86,1.72)). Conclusion These findings from a resource-constrained country highlight the importance of surveillance systems to track emerging infections and their risk factors. In addition to co-morbidities described elsewhere, tuberculosis was a risk factor for moderate-to-severe COVID-19 disease.